Interleukin 5 (IL-5) is an interleukin produced by type-2 T helper cells and mast cells.

Jan 8, 2019 · Anti-interleukin-5 therapy is approved for patients with refractory asthma with an eosinophilic phenotype. The severe asthma care team at Mayo Clinic has expertise in …

Interleukin-5 (IL-5) exerts a central pathogenic role in differentiation, recruitment, survival, and degranulation of eosinophils.

While interleukin-5 (IL-5) is initially identified by its ability to support the growth and terminal differentiation of mouse B cells in vitro into antibody-secreting cells, recombinant IL-5 exerts …

Interleukin-5 (IL-5) is a cytokine that is primarily produced by activated CD4+ helper T cells, mast cells, and eosinophils. It is responsible for stimulating the functions of eosinophils, which are a …

Interleukin 5 (IL-5) is a major cytokine responsible for eosinophil proliferation, migration and degranulation. Eosinophils play a considerable role in the manifestation of type 2 asthma, and …

Interleukin-5 (IL-5) is a nonspecific marker associated with a Th2 (helper T cells, subset 2)-immune response and is not diagnostic for any specific disease or disease process. Elevated …

3 days ago · To the Editor, We have reviewed with interest the article by Buchheit et al. titled ‘Interleukin-5 as a pleiotropic cytokine orchestrating airway type 2 inflammation: Effects on and …

IL-5 is a T-cell-derived cytokine involved in the pathogenesis of atopic diseases. It specifically controls the production, activation, and localization of eosinophils. Eosinophils mediate allergic …

Sep 1, 2017 · Mechanism of Action: Mepolizumab is an interleukin-5 antagonist (IgG1 kappa). IL-5 is the major cytokine responsible for the growth and differentiation, recruitment, activation, …